-
公开(公告)号:NO311025B1
公开(公告)日:2001-10-01
申请号:NO981522
申请日:1998-04-03
Applicant: BASF AG
Inventor: KLINGE DAGMAR , AMBERG WILHELM , KLING ANDREAS , RIECHERS HARTMUT , UNGER LILIANE , RASCHACK MANFRED
IPC: A61K31/00 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K31/505 , A61K31/53 , A61P5/24 , A61P5/36 , A61P5/42 , A61P9/12 , C07D213/74 , C07D239/10 , C07D239/42 , C07D239/46 , C07D239/48 , C07D239/50 , C07D239/52 , C07D239/58 , C07D251/46 , C07D401/04 , C07D405/12 , C07D405/14 , C07D471/04 , C07D487/04 , C07D491/052 , C07D491/056
Abstract: The invention relates to amino acid derivatives of the formula Iwhere the radicals have the meanings stated in the description, and to the use thereof as drugs.
-
公开(公告)号:TR200100427T2
公开(公告)日:2001-07-23
申请号:TR200100427
申请日:1999-08-07
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KETTSCHAU GEORG , HERGENROEDER STEFAN , RASCHACK MANFERD , UNGER LILIANE
IPC: C07D251/22 , A61K31/505 , A61K31/517 , A61K31/519 , A61K31/53 , A61K45/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/52 , C07D401/12 , C07D403/12 , C07D405/12 , C07D491/048 , C07D495/04
Abstract: The invention relates to new carboxylic acid derivatives of the formula (I), where the substituents have the meaning given in the description, their production and their use as endothelin-receptor antagonists.
-
公开(公告)号:BG63201B1
公开(公告)日:2001-06-29
申请号:BG10281498
申请日:1998-10-05
Applicant: BASF AG
Inventor: RIECHERS HARTMUT , KLINGE DAGMAR , AMBERG WILHELM , KLING ANDREAS , HILLEN HEINZ , UNGER LILIANE , ELGER BERND
IPC: C07D251/30 , A61K31/00 , A61K31/505 , A61K31/517 , A61K31/529 , A61K31/53 , A61P7/00 , A61P9/00 , A61P9/02 , A61P9/12 , A61P13/00 , A61P13/08 , A61P13/12 , C07D239/34 , C07D239/46 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/48 , C07D403/12 , C07D491/044
Abstract: The invention relates to derivatives of carboxylic acids with the formula where the radicals have the meanings listed in the description, as well to the preparation of these compounds and their application as medicamentous forms. 9 claims
-
公开(公告)号:CZ20010068A3
公开(公告)日:2001-06-13
申请号:CZ20010068
申请日:1999-06-23
Applicant: BASF AG , BASF BIORES CORP
Inventor: RITTER KURT , JANSSEN BERND , HAUPT ANDREAS , KLING ANDREAS , BARLOZZARI TERESA , AMBERG WILHELM
-
公开(公告)号:BG104722A
公开(公告)日:2001-05-31
申请号:BG10472200
申请日:2000-08-28
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLINGE DAGMAR
IPC: C07D239/38 , A61K31/19 , A61K31/215 , A61K31/357 , A61K31/36 , A61K31/505 , A61P43/00 , C07C319/14 , C07C323/56 , C07D239/56 , C07D239/60 , C07D317/62 , C07D317/56 , C07C323/22
Abstract: The invention relates to a method for preparing sulfanyl-type endothelin receptor antagonists of general formula wherein R1 represents hydroxy, alkoxy, sulfonamidyl, amino; R2 represents alkyl, aryl or heteroaryl, optionally substituted, and R3, R 4, R5 can be the same or different and are alkyl or aryl, optionally substituted, by means of nucleophilic reaction of a carboxylic acid derivative of formula with a sulfide of formula X being SR6 or SO2R6 and R6 being alkyl or aryl, optionally substituted. 5 claims
-
公开(公告)号:HU0000664A2
公开(公告)日:2001-04-28
申请号:HU0000664
申请日:1997-09-02
Applicant: BASF AG
Inventor: AMBERG WILHELM , HERGENROEDER STEFAN , JANSEN ROLF , DR KLING ANDREAS , DR KLINGE DAGMAR , RASCHACK MANFRED , DR RIECHERS HARTMUT , DR UNGER LILIANE
IPC: A61K31/505 , A61K31/506 , A61K31/519 , A61P9/04 , A61P9/08 , A61P9/12 , A61P43/00 , C07C59/66 , C07C69/734 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D491/04 , C07D491/048
Abstract: The invention relates to carboxylic acid derivatives of the formula Iwhere the radicals have the meanings stated in the description, and to their use as drugs.
-
公开(公告)号:PL180652B1
公开(公告)日:2001-03-30
申请号:PL32115995
申请日:1995-04-26
Applicant: BASF AG
Inventor: AMBERG WILHELM , BERNARD HARALD , BUSCHMANN ERNST , HAUPT ANDREAS , JANITSCHKE LOTHAR , JANSSEN BERND , KARL ULRICH , KLING ANDREAS , MUELLER STEFAN , DE POTZOLLI BERND , RITTER KURT , THYES MARCO , ZIERKE THOMAS
Abstract: PCT No. PCT/EP95/01577 Sec. 371 Date Nov. 4, 1996 Sec. 102(e) Date Nov. 4, 1996 PCT Filed Apr. 26, 1995 PCT Pub. No. WO95/30691 PCT Pub. Date Nov. 16, 1995The compound Me2Val-Val-MeVal-Pro-Pro-NHBzlxHCl is described. It is prepared from Z-Val-Val-MeVal-Pro-OR1 where Z and R1 have the meanings stated in the description. The compound shows antineoplastic activity.
-
公开(公告)号:NZ319595A
公开(公告)日:2001-03-30
申请号:NZ31959596
申请日:1996-09-26
Applicant: BASF AG
Inventor: KLINGE DAGMAR , AMBERG WILHELM , KLING ANDREAS , RIECHERS HARTMUT , UNGER LILIANE , RASCHACK MANFRED
IPC: A61K31/00 , A61K31/44 , A61K31/4427 , A61K31/443 , A61K31/444 , A61K31/505 , A61K31/53 , A61P5/24 , A61P5/36 , A61P5/42 , A61P9/12 , C07D213/74 , C07D239/10 , C07D239/42 , C07D239/46 , C07D239/48 , C07D239/50 , C07D239/52 , C07D239/58 , C07D251/46 , C07D401/04 , C07D405/12 , C07D405/14 , C07D471/04 , C07D487/04 , C07D491/052 , C07D491/056 , C07D251/12 , C07D403/06
Abstract: The amino acid derivatives of formula (I) are endothelin antagonists. The compounds may be used in medicaments to treat hypertension, myocardial infarct, angina pectoris, acute kidney failure, renal insufficiency, cerebral vasospasms, cerebral ischemia, subarachnoid hemorrhages, migraine, asthma, atherosclerosis, endotoxic shock, intravascular coagulation, restenosis following angioplasty, benign prostate hyperplasia and ischemic kidney failure. In formula (I); R is COOH or a radical which can be hydrolyzed to COOH; W is nitrogen; R2 is hydrogen, halogen, C1-4 alkyl, C1-4 haloalkyl, C1-4 alkoxy, C1-4 haloalkoxy, hydroxyl, mercapto, C1-C4-alkylthio, nitro, amino, C1-C4-alkylamino or C1-C4-dialkylamino, cyano, optionally substituted phenyl, or an optionally substituted five-or six-membered heteroaromatic ring which contains from one to three N atoms and/or one S or O; or R2 can furthermore form with the adjacent carbon atom and X, a 5- or 6-membered alkylene or alkylidene ring in which, in each case, one or two carbon atoms can be replaced by a N, S or O hetero atom and which can be mono- to trisubstituted by the following radicals: halogen, nitro, cyano, hydroxyl, mercapto, C1-C3 alkyl, C1-C3 haloalkyl, C1-C3 alkoxy, C1-C3 alkylthio, amino, C1-C3 alkylamino, C1-C3 dialkylamino; R3 can have the same meaning as R2, or furthermore form together with the adjacent carbon atom and Y, an optionally substituted 5- or 6-embered alkylene or alkylidene ring in which, in each case, one or two carbon atoms can be replaced by N, O or S; X is nitrogen or CR15, where R15 is hydrogen or C1-C5-alkyl, C1-C5-alkoxy, C1-C5-alkylthio, nitro, phenyl, hydroxyl, mercapto, halogen, amino, C1-C4-alkylamino, C1-C4-dialkylamino or cyano, or CR15 is linked to R2 to form a 5- or 6-membered ring as described above, or CR15 can form together with R3 and its adjacent carbon atom a 5- or 6-membered ring as described above; Y is nitrogen or CR16, where R16 is the same as R15, or CR16 forms together with R3 and its adjacent carbon atom a 5- or 6-membered ring as described above; R4 is hydrogen, C1-C7-alkyl, C3-C7-cycloalkyl, or optionally substituted phenyl or naphthyl; or R4 can be an optionally substituted 5- or 6-membered heteroaromatic ring which contains one N, O or S atom, or R4 and R5 can be phenyl groups which are connected to each other in the ortho positions by a direct linkage, a methylene, ethylene or ethenylene group, an O or S atom or an SO2, NH or N-alkyl group; R5 is C1-C7-alkyl, C3-C7-cycloalkyl or phenyl or naphthyl which can be substituted by 1 to 3 of the following radicals; halogen, nitro, cyano, hydroxyl, C1-C4-alkyl, C1-C4-haloalkyl, C1-C4-alkoxy, C1-C4-haloalkoxy, phenoxy, phenyl, C1-C4-alkylthio, amino, C1-C4-alkylamino or C1-C4-dialkylamino, or the radicals depicted above; or R5 can be an optionally substituted 5- or 6-membered hetero aromatic ring with one N, S or O heteroatoms; or R5 can form together with R4 a tricyclic system, or R5 can be an optionally substituted phenyl or heteroaromatic radical as described above, which is linked in the ortho position to R8 to form a 6-membered ring where Q must be a single bond and R8 must be a CH-R17 group; R6 is hydrogen or C1-C4-alkyl or C1-C4 haloalkyl; Z is a single bond, O, S, sulfinyl or sulfonyl; R7 is hydrogen, or C1-C4 alkyl, C2-C4-alkenyl, C2-C4-alkynyl; Q is a single bond, a C=O, or C(=O)O group; and R8 is hydrogen, C1-C4-alkyl, C2-C4-alkenyl, phenyl or benzyl, and R8 can furthermore be directly connected to R5 as described above, in which case R8 is a CH-R17 group, where R17 is hydrogen, C1-C4-alkyl, phenyl or phenyl which is mono- to trisubstituted by methoxy, or R8 is a radical as depicted above.
-
199.
公开(公告)号:BG104222A
公开(公告)日:2001-02-28
申请号:BG10422200
申请日:2000-03-06
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KLINGE DAGMAR , RIECHERS HARTMUT , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: A61K31/421 , A61K31/426 , A61K31/428 , A61K31/496 , A61K31/505 , A61P9/10 , A61P9/12 , A61P43/00 , C07D239/34 , C07D239/52 , C07D263/38 , C07D277/20 , C07D277/34 , C07D277/68 , C07D409/12 , C07D239/04
Abstract: The invention relates to carboxylic acid derivatives of formula wherein the radical are defined in the description, and to the use of these derivatives as ETA/ETB endothelin receptor antagonists. 2 claims
-
公开(公告)号:NO20010622L
公开(公告)日:2001-02-06
申请号:NO20010622
申请日:2001-02-06
Applicant: BASF AG
Inventor: AMBERG WILHELM , JANSEN ROLF , KETTSCHAU GEORG , HERGENROEDER STEFAN , RASCHACK MANFRED , UNGER LILIANE
IPC: C07D251/22 , A61K31/505 , A61K31/517 , A61K31/519 , A61K31/53 , A61K45/00 , A61P9/04 , A61P9/10 , A61P9/12 , A61P13/08 , A61P13/12 , A61P35/00 , A61P43/00 , C07D239/34 , C07D239/52 , C07D239/60 , C07D239/70 , C07D251/52 , C07D401/12 , C07D403/12 , C07D405/12 , C07D491/048 , C07D495/04
Abstract: The invention relates to new carboxylic acid derivatives of the formula (I), where the substituents have the meaning given in the description, their production and their use as endothelin-receptor antagonists.
-
-
-
-
-
-
-
-
-